Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HELZ | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | RNF44 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | UBE2D2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | RHOU | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | UNC13A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | ASNS | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | SMIM3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | HPSE2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |